Euro-Sante :: Euro-Health

Archives for health policy

NICE is the health technology assessment [HTA] agency in England, the one upon which others in many countries are modelled. More generally, HTA is increasingly being used by governments for more than simple economic evaluation of medicines and devices, but is being used as a form of rationing of access to technologies (medicines or devices… » read more

Posted by EuroSante

The Swedish presidency has identified a number of health priorities. I’d like to reflect on the following: 1. patient mobility directive, 2. e-health cooperation, and 3. flu. Patient mobility adds cross-border health risk as people with diseases move around. Zoonoses, diseases caught from animals (and it is worth remembering that animals catch diseases from humans,… » read more

Posted by EuroSante

The British have raised the issue that cross-border healthcare will only benefit the few: All EU citizens, not just the wealthy or well informed, must be able to benefit Baroness Howarth of Breckland, of the House of Lords’ EU Committee Is this fear or concern justified? The whole point of enabling European citizens to have… » read more

Posted by EuroSante

The Innovative Medicines Initiative seeks to put right the chaotic treatment of pharmaceutical innovation by EU member states, and will likely fail. The goose that lays golden eggs of medical innovation is cooked to death by member state medicines policies. Increasing the speed of product development will come to a grinding halt as member states… » read more

Posted by EuroSante